ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure

Sacubitril/valsartan (S/V) has been shown to reduce the risk of cardiovascular death or heart failure hospitalization and improve symptoms in chronic heart failure with reduced ejection fraction compared with enalapril. After 7 years since the publication of the results of PARADIGM-HF, further insig...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Tano, Giuseppe, Di Lenarda, Andrea, Iacoviello, Massimo, Oliva, Fabrizio, Urbinati, Stefano, Aspromonte, Nadia, Cipriani, Manlio, Caldarola, Pasquale, Murrone, Adriano, Gulizia, Michele Massimo, Colivicchi, Furio, Gabrielli, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388607/
https://www.ncbi.nlm.nih.gov/pubmed/34456644
http://dx.doi.org/10.1093/eurheartj/suab078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388607/
https://www.ncbi.nlm.nih.gov/pubmed/34456644
http://dx.doi.org/10.1093/eurheartj/suab078

Ejemplares similares